Hongxi Wu

990 total citations
25 papers, 747 citations indexed

About

Hongxi Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Hongxi Wu has authored 25 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Hongxi Wu's work include Ubiquitin and proteasome pathways (5 papers), Prostate Cancer Treatment and Research (5 papers) and Protein Degradation and Inhibitors (4 papers). Hongxi Wu is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Prostate Cancer Treatment and Research (5 papers) and Protein Degradation and Inhibitors (4 papers). Hongxi Wu collaborates with scholars based in China, Singapore and United States. Hongxi Wu's co-authors include Yong Yang, Xin‐Ying Tang, Qiuhua Cao, Zhipeng You, Yulan Zhang, Fu Gui, Zhen Chen, Xinghua Gao, Guangjiang Shi and Shuhua Fu and has published in prestigious journals such as Hepatology, Cancer Research and Oncogene.

In The Last Decade

Hongxi Wu

22 papers receiving 743 citations

Peers

Countries citing papers authored by Hongxi Wu

Since Specialization

Citations

This map shows the geographic impact of Hongxi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxi Wu more than expected).

Fields of papers citing papers by Hongxi Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxi Wu. The network helps show where Hongxi Wu may publish in the future.

Co-authorship network of co-authors of Hongxi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxi Wu. A scholar is included among the top collaborators of Hongxi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxi Wu. Hongxi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cancer Biology of GSPT1: Mechanisms and Targeted Therapy Opportunities of Molecular Glue Degraders 2025 ·Advanced Science ·Qiaoli Lin, Wenjing Liu, Wenjia Lu, Ming-Jie Zhao, Lin Cao, Zhiyu Li, Jubo Wang, Xi Xu, Hongxi Wu	0
2	Combination strategies with STING agonists: Current advances and future directions 2025 ·European Journal of Pharmacology ·Kang Sun, Xiao Fu, (unknown), Fangzhou Liu, (unknown), (unknown), (unknown), Jinlei Bian, Zhiyu Li, (unknown), Hongxi Wu	0
3	Discovery of CLKs inhibitors for the treatment of non-small cell lung cancer 2024 ·European Journal of Medicinal Chemistry ·Tianxing Hu, (unknown), Rui Chen, Hui Zhang, (unknown), (unknown), Wenyi Zhou, Dechun Huang, (unknown), Depeng Li, Zhiyu Li, Hongxi Wu, Jinlei Bian	0
4	Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib‐Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency 2024 ·Advanced Science ·(unknown), Xiankang Zhang, Hui Zhang, Yu Li, Huidan Huang, Zhiyu Li, Zhixia Qiu, Hongxi Wu, Dechun Huang, Xi Xu, Jinlei Bian	6
5	Discovery of a photoactivatable dimerized STING agonist based on the benzo[b]selenophene scaffold 2023 ·Chemical Science ·Dongyu Liu, Bin Yu, Xin‐Yuan Guan, Bin Song, (unknown), (unknown), (unknown), Lixia Pan, Huidan Huang, Zhe Wang, Hongxi Wu, Zhixia Qiu, Zhiyu Li, Jinlei Bian	12
6	2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop 2021 ·Pharmacological Research ·Shufang Zheng, (unknown), Ying Li, (unknown), Yuchen Yao, (unknown), (unknown), (unknown), (unknown), (unknown), Zhuo Wang, Yong Yang, Zhen Chen, Hongxi Wu, Weiwei Hu	12
7	Hepatic interferon regulatory factor 8 expression mediates liver ischemia/reperfusion injury in mice 2021 ·Biochemical Pharmacology ·Guangjiang Shi, Zixuan Zhang, (unknown), Yan Li, (unknown), (unknown), Yuan Li, Xin‐Ying Tang, Yong Yang, Zhen Chen, Zhuo Wang, Hongxi Wu	6
8	Identification of novel androgen receptor degrading agents to treat advanced prostate cancer 2021 ·European Journal of Medicinal Chemistry ·Hongxi Wu, Jie Ren, Lulu Zhao, Zhiyu Li, Wanli Ye, Yong Yang, Jubo Wang, Jinlei Bian	6
9	Drp1 knockdown represses apoptosis of rat retinal endothelial cells by inhibiting mitophagy 2021 ·Acta Histochemica ·Hongxi Wu, Guodong Li, Weiwei Chen, Wenbin Luo, (unknown), Zhipeng You, (unknown)	18
10	Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance 2020 ·Cancer Research ·Hongxi Wu, Linjun You, (unknown), Zhili Zhao, Guangjiang Shi, Zhen Chen, Zhuo Wang, Xianjing Li, (unknown), Wanli Ye, (unknown), Jingjing Duan, Yan Cheng, (unknown), Jin‐Song Bian, Jin‐Rong Zhou, (unknown), Yong Yang	15
11	Hypoxia-induced myeloid derived growth factor promotes hepatocellular carcinoma progression through remodeling tumor microenvironment 2020 ·Theranostics ·Xu Wang, Jie Mao, Tao Zhou, Xingyi Chen, (unknown), (unknown), Yixuan Li, (unknown), Yong Yang, Hongxi Wu, Xin‐Ying Tang	40
12	Discovery of pyridine tetrahydroisoquinoline thiohydantoin derivatives with low blood-brain barrier penetration as the androgen receptor antagonists 2020 ·European Journal of Medicinal Chemistry ·Xi Xu, Qianming Du, Ying Meng, Zhiyu Li, Hongxi Wu, Yan Li, Zhili Zhao, (unknown), Xiaoyu Lu, (unknown), Xijing Chen, Yong Yang, Jubo Wang, Jinlei Bian	7
13	Endothelial Dysfunction in Diabetic Retinopathy 2020 ·Frontiers in Endocrinology ·Fu Gui, Zhipeng You, Shuhua Fu, Hongxi Wu, Yulan Zhang	129
14	Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells 2018 ·Clinical Cancer Research ·Yan Cheng, Xin‐Ying Tang, Yixuan Li, Dandan Zhao, Qiuhua Cao, Hongxi Wu, Hongbao Yang, Kun Hao, Yong Yang	70
15	In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature 2018 ·Biomedicine & Pharmacotherapy ·Guangjiang Shi, Yan Li, Qiuhua Cao, Hongxi Wu, Xin‐Ying Tang, Xinghua Gao, Jianqiang Yu, Zhen Chen, Yong Yang	231
16	Transplantation of rat embryonic stem cell-derived retinal cells restores visual function in the Royal College of Surgeons rats 2018 ·Documenta Ophthalmologica ·Hongxi Wu, Jia Li, (unknown), Guodong Li, (unknown), Zhipeng You	6
17	Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway 2018 ·Oncogene ·Yan Cheng, Xinghua Gao, (unknown), Qiuhua Cao, Dandan Zhao, Jin‐Rong Zhou, Hongxi Wu, Yun Wang, Linjun You, Hongbao Yang, Yunlong He, Yongren Li, Jin‐Song Bian, Qingyi Zhu, Lutz Birnbaumer, Yong Yang	56
18	SHC004-221A1, a novel tyrosine kinase, potently inhibits T315I mutant BCR-ABL in chronic myeloid leukemia 2017 ·European Journal of Pharmacology ·Duowei Wang, Yan Zheng, Jiaying Li, Hongxi Wu, Xianjing Li, (unknown), Yang Liu, Jiani Li, Rui Sun, (unknown), Jihong Sun, Yong Yang	5
19	MiR‐21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway 2016 ·Cell Biology International ·Fu Gui, Zhengdong Hong, Zhipeng You, Hongxi Wu, Yulan Zhang	34
20	Combination of sorafenib and enzalutamide as a potential new approach for the treatment of castration-resistant prostate cancer 2016 ·Cancer Letters ·Hongxi Wu, Lulu Zhang, (unknown), (unknown), Jingjing Duan, Linjun You, Yan Cheng, Jin‐Song Bian, (unknown), Yong Yang	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact